InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

LYRA stock results show that Lyra Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

FBRX Stock Earnings: Forte Biosciences Misses EPS for Q2 2024

By InvestorPlace Earnings

FBRX stock results show that Forte Biosciences missed analyst estimates for earnings per share the second quarter of 2024.

GNLX Stock Earnings: Genelux Beats EPS for Q2 2024

By InvestorPlace Earnings

GNLX stock results show that Genelux beat analyst estimates for earnings per share the second quarter of 2024.

GAME Stock Earnings: GameSquare Holdings Misses EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

GAME stock results show that GameSquare Holdings missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024

By InvestorPlace Earnings

TSBX stock results show that Turnstone Biologics missed analyst estimates for earnings per share the second quarter of 2024.

Load More